1. Home
  2. KIO vs MLAB Comparison

KIO vs MLAB Comparison

Compare KIO & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KIO
  • MLAB
  • Stock Information
  • Founded
  • KIO 2011
  • MLAB 1982
  • Country
  • KIO United States
  • MLAB United States
  • Employees
  • KIO 2400
  • MLAB N/A
  • Industry
  • KIO Investment Managers
  • MLAB Industrial Machinery/Components
  • Sector
  • KIO Finance
  • MLAB Industrials
  • Exchange
  • KIO Nasdaq
  • MLAB Nasdaq
  • Market Cap
  • KIO 522.7M
  • MLAB 441.2M
  • IPO Year
  • KIO N/A
  • MLAB N/A
  • Fundamental
  • Price
  • KIO $11.59
  • MLAB $71.32
  • Analyst Decision
  • KIO
  • MLAB Hold
  • Analyst Count
  • KIO 0
  • MLAB 1
  • Target Price
  • KIO N/A
  • MLAB $67.00
  • AVG Volume (30 Days)
  • KIO 136.5K
  • MLAB 100.9K
  • Earning Date
  • KIO 01-01-0001
  • MLAB 11-06-2025
  • Dividend Yield
  • KIO 10.82%
  • MLAB 0.87%
  • EPS Growth
  • KIO N/A
  • MLAB N/A
  • EPS
  • KIO N/A
  • MLAB N/A
  • Revenue
  • KIO N/A
  • MLAB $245,255,000.00
  • Revenue This Year
  • KIO N/A
  • MLAB $5.38
  • Revenue Next Year
  • KIO N/A
  • MLAB $5.25
  • P/E Ratio
  • KIO N/A
  • MLAB N/A
  • Revenue Growth
  • KIO N/A
  • MLAB 7.39
  • 52 Week Low
  • KIO $10.52
  • MLAB $55.45
  • 52 Week High
  • KIO $13.59
  • MLAB $155.12
  • Technical
  • Relative Strength Index (RSI)
  • KIO 30.47
  • MLAB 43.14
  • Support Level
  • KIO $11.93
  • MLAB $70.00
  • Resistance Level
  • KIO $12.12
  • MLAB $82.37
  • Average True Range (ATR)
  • KIO 0.10
  • MLAB 4.40
  • MACD
  • KIO -0.02
  • MLAB -0.59
  • Stochastic Oscillator
  • KIO 5.37
  • MLAB 11.64

About KIO KKR Income Opportunities Fund

KKR Income Opportunities Fund operates as a closed-end registered management investment company. It seeks to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in the portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

Share on Social Networks: